Epalrestat

• Target :

  Reductase

• Related Pathways :

  Endocrinology/Hormones|||Metabolism

• Purity :

  0.9954

• Bioactivity :

  Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particularly in patients with limited microangiopathy and good glycemic control.

• Smiles :

  CC(=C/C1=CC=CC=C1)\C=C1/SC(=S)N(CC(O)=O)C1=O

• Molecular Formula :

  C15H13NO3S2

• Molecular Weight :

  319.4

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  82159-09-9